IDXX logo

IDEXX Laboratories (IDXX) Cash From Financing

IDXX Annual CFF

-$442.00 M
-$71.06 M-19.16%

31 December 2023

IDXX Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IDXX Quarterly CFF

-$290.98 M
-$80.74 M-38.40%

30 September 2024

IDXX Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IDXX TTM CFF

-$747.13 M
-$247.94 M-49.67%

30 September 2024

IDXX TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IDXX Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-19.2%-576.1%-63.5%
3 y3 years-77.9%-149.3%-101.4%
5 y5 years+26.1%-149.3%-101.4%

IDXX Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-19.2%+36.6%-2058.6%at low-101.4%at low
5 y5-year-77.9%+36.6%-1821.7%at low-200.8%at low
alltimeall time-376.8%+36.6%-288.7%+10.5%-567.0%at low

IDEXX Laboratories Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
-$290.98 M(+38.4%)
-$747.13 M(+49.7%)
June 2024
-
-$210.24 M(+45.9%)
-$499.19 M(+13.5%)
Mar 2024
-
-$144.07 M(+41.5%)
-$439.99 M(-0.5%)
Dec 2023
-$442.00 M(+19.2%)
-$101.84 M(+136.6%)
-$442.00 M(-3.3%)
Sept 2023
-
-$43.04 M(-71.5%)
-$456.87 M(-18.8%)
June 2023
-
-$151.03 M(+3.4%)
-$562.66 M(+11.7%)
Mar 2023
-
-$146.08 M(+25.2%)
-$503.54 M(+35.7%)
Dec 2022
-$370.94 M(-46.8%)
-$116.72 M(-21.6%)
-$370.94 M(-11.7%)
Sept 2022
-
-$148.83 M(+61.9%)
-$420.04 M(-14.8%)
June 2022
-
-$91.91 M(+581.8%)
-$492.93 M(-15.2%)
Mar 2022
-
-$13.48 M(-91.9%)
-$581.24 M(-16.7%)
Dec 2021
-$697.41 M(+180.7%)
-$165.82 M(-25.2%)
-$697.41 M(+31.3%)
Sept 2021
-
-$221.73 M(+23.0%)
-$531.20 M(+28.4%)
June 2021
-
-$180.22 M(+39.0%)
-$413.65 M(+4.7%)
Mar 2021
-
-$129.65 M(<-9900.0%)
-$394.97 M(+59.0%)
Dec 2020
-$248.42 M(-13.3%)
$398.00 K(-100.4%)
-$248.42 M(-23.1%)
Sept 2020
-
-$104.18 M(-35.5%)
-$323.20 M(+1.4%)
June 2020
-
-$161.53 M(-1055.7%)
-$318.77 M(+19.5%)
Mar 2020
-
$16.90 M(-122.7%)
-$266.73 M(-6.9%)
Dec 2019
-$286.41 M(-52.1%)
-$74.39 M(-25.4%)
-$286.41 M(-13.2%)
Sept 2019
-
-$99.75 M(-8.9%)
-$329.83 M(+4.9%)
June 2019
-
-$109.49 M(+3837.0%)
-$314.37 M(+14.1%)
Mar 2019
-
-$2.78 M(-97.6%)
-$275.59 M(-53.9%)
Dec 2018
-$597.80 M(+187.4%)
-$117.81 M(+39.8%)
-$597.80 M(+7.1%)
Sept 2018
-
-$84.29 M(+19.2%)
-$558.05 M(+3.0%)
June 2018
-
-$70.71 M(-78.2%)
-$541.63 M(+1.4%)
Mar 2018
-
-$324.99 M(+316.3%)
-$534.32 M(+156.9%)
Dec 2017
-$208.02 M(-6.4%)
-$78.06 M(+15.0%)
-$208.02 M(+0.4%)
Sept 2017
-
-$67.87 M(+7.1%)
-$207.21 M(-0.7%)
June 2017
-
-$63.40 M(-4928.6%)
-$208.59 M(-4.5%)
Mar 2017
-
$1.31 M(-101.7%)
-$218.32 M(-1.7%)
Dec 2016
-$222.20 M(+120.0%)
-$77.25 M(+11.6%)
-$222.20 M(+6.0%)
Sept 2016
-
-$69.25 M(-5.3%)
-$209.54 M(+16.4%)
June 2016
-
-$73.14 M(+2754.6%)
-$179.96 M(+28.2%)
Mar 2016
-
-$2.56 M(-96.0%)
-$140.35 M(+39.0%)
Dec 2015
-$100.99 M(-2.4%)
-$64.60 M(+62.9%)
-$100.99 M(-1798.7%)
Sept 2015
-
-$39.66 M(+18.3%)
$5.95 M(-119.4%)
June 2015
-
-$33.53 M(-191.1%)
-$30.66 M(-40.7%)
Mar 2015
-
$36.80 M(-13.1%)
-$51.68 M(-50.0%)
Dec 2014
-$103.44 M(+1.0%)
$42.34 M(-155.5%)
-$103.44 M(-42.2%)
Sept 2014
-
-$76.27 M(+39.8%)
-$178.83 M(+25.1%)
June 2014
-
-$54.55 M(+264.6%)
-$142.90 M(+19.4%)
Mar 2014
-
-$14.96 M(-54.7%)
-$119.66 M(+16.8%)
Dec 2013
-$102.45 M(-18.3%)
-$33.05 M(-18.0%)
-$102.45 M(-14.1%)
Sept 2013
-
-$40.33 M(+28.8%)
-$119.24 M(+2.7%)
June 2013
-
-$31.32 M(-1490.6%)
-$116.14 M(-0.3%)
Mar 2013
-
$2.25 M(-104.5%)
-$116.53 M(-7.0%)
Dec 2012
-$125.34 M(+28.4%)
-$49.85 M(+33.9%)
-$125.34 M(+75.3%)
Sept 2012
-
-$37.23 M(+17.4%)
-$71.49 M(+1.0%)
June 2012
-
-$31.70 M(+383.0%)
-$70.78 M(-12.4%)
Mar 2012
-
-$6.56 M(-263.7%)
-$80.77 M(-17.3%)
Dec 2011
-$97.66 M(+12.5%)
$4.01 M(-111.0%)
-$97.66 M(-13.7%)
Sept 2011
-
-$36.53 M(-12.4%)
-$113.16 M(+4.1%)
June 2011
-
-$41.69 M(+77.8%)
-$108.70 M(+8.0%)
Mar 2011
-
-$23.45 M(+104.1%)
-$100.61 M(+16.0%)
Dec 2010
-$86.77 M(-8.9%)
-$11.49 M(-64.2%)
-$86.77 M(-27.7%)
Sept 2010
-
-$32.07 M(-4.6%)
-$120.03 M(+8.8%)
June 2010
-
-$33.60 M(+249.9%)
-$110.37 M(+2.0%)
Mar 2010
-
-$9.60 M(-78.5%)
-$108.18 M(+13.5%)
Dec 2009
-$95.30 M(+209.5%)
-$44.76 M(+99.8%)
-$95.30 M(+33.8%)
Sept 2009
-
-$22.40 M(-28.7%)
-$71.22 M(+30.5%)
June 2009
-
-$31.42 M(-1056.5%)
-$54.56 M(+4.4%)
Mar 2009
-
$3.29 M(-115.9%)
-$52.27 M(+69.8%)
Dec 2008
-$30.79 M
-$20.68 M(+260.2%)
-$30.79 M(+36.1%)
Sept 2008
-
-$5.74 M(-80.3%)
-$22.63 M(-5.2%)
June 2008
-
-$29.14 M(-217.6%)
-$23.86 M(-44.1%)
DateAnnualQuarterlyTTM
Mar 2008
-
$24.77 M(-297.8%)
-$42.71 M(+134.8%)
Dec 2007
-$18.19 M(-76.2%)
-$12.52 M(+79.5%)
-$18.19 M(+21.5%)
Sept 2007
-
-$6.97 M(-85.5%)
-$14.97 M(+81.3%)
June 2007
-
-$47.98 M(-197.3%)
-$8.26 M(-616.0%)
Mar 2007
-
$49.29 M(-629.7%)
$1.60 M(-102.1%)
Dec 2006
-$76.26 M(-28.7%)
-$9.30 M(+3492.7%)
-$76.26 M(-22.2%)
Sept 2006
-
-$259.00 K(-99.3%)
-$98.02 M(-25.4%)
June 2006
-
-$38.13 M(+33.4%)
-$131.48 M(+22.5%)
Mar 2006
-
-$28.57 M(-8.0%)
-$107.35 M(+0.3%)
Dec 2005
-$106.98 M(-2.9%)
-$31.07 M(-7.8%)
-$106.98 M(-2.1%)
Sept 2005
-
-$33.72 M(+141.0%)
-$109.28 M(-1.5%)
June 2005
-
-$13.99 M(-50.4%)
-$110.91 M(-12.5%)
Mar 2005
-
-$28.21 M(-15.4%)
-$126.71 M(+15.0%)
Dec 2004
-$110.17 M(+2034.3%)
-$33.36 M(-5.6%)
-$110.17 M(+32.5%)
Sept 2004
-
-$35.35 M(+18.6%)
-$83.12 M(+120.3%)
June 2004
-
-$29.80 M(+155.4%)
-$37.73 M(+206.3%)
Mar 2004
-
-$11.67 M(+84.8%)
-$12.32 M(+138.6%)
Dec 2003
-$5.16 M(-79.6%)
-$6.31 M(-162.8%)
-$5.16 M(-179.4%)
Sept 2003
-
$10.05 M(-329.2%)
$6.50 M(-350.8%)
June 2003
-
-$4.38 M(-2.8%)
-$2.59 M(-91.9%)
Mar 2003
-
-$4.51 M(-184.3%)
-$32.12 M(+26.8%)
Dec 2002
-$25.34 M(-2872.8%)
$5.35 M(+462.2%)
-$25.34 M(-7.4%)
Sept 2002
-
$952.00 K(-102.8%)
-$27.36 M(+0.9%)
June 2002
-
-$33.91 M(-1595.4%)
-$27.12 M(-287.1%)
Mar 2002
-
$2.27 M(-32.1%)
$14.50 M(+1486.1%)
Dec 2001
$914.00 K(-101.4%)
$3.34 M(+180.9%)
$914.00 K(-104.5%)
Sept 2001
-
$1.19 M(-84.6%)
-$20.48 M(-67.7%)
June 2001
-
$7.70 M(-168.1%)
-$63.48 M(-10.3%)
Mar 2001
-
-$11.31 M(-37.3%)
-$70.78 M(+11.7%)
Dec 2000
-$63.35 M(-1.0%)
-$18.05 M(-56.8%)
-$63.35 M(-26.7%)
Sept 2000
-
-$41.81 M(<-9900.0%)
-$86.40 M(+18.5%)
June 2000
-
$402.00 K(-110.3%)
-$72.89 M(+3.5%)
Mar 2000
-
-$3.89 M(-90.5%)
-$70.39 M(+10.0%)
Dec 1999
-$64.00 M(-2100.0%)
-$41.10 M(+45.2%)
-$64.00 M(+213.7%)
Sept 1999
-
-$28.30 M(-1075.9%)
-$20.40 M(-372.0%)
June 1999
-
$2.90 M(+16.0%)
$7.50 M(+10.3%)
Mar 1999
-
$2.50 M(0.0%)
$6.80 M(+112.5%)
Dec 1998
$3.20 M(+113.3%)
$2.50 M(-725.0%)
$3.20 M(+88.2%)
Sept 1998
-
-$400.00 K(-118.2%)
$1.70 M(+30.8%)
June 1998
-
$2.20 M(-300.0%)
$1.30 M(-750.0%)
Mar 1998
-
-$1.10 M(-210.0%)
-$200.00 K(-113.3%)
Dec 1997
$1.50 M(-85.0%)
$1.00 M(-225.0%)
$1.50 M(-71.7%)
Sept 1997
-
-$800.00 K(-214.3%)
$5.30 M(-30.3%)
June 1997
-
$700.00 K(+16.7%)
$7.60 M(-19.1%)
Mar 1997
-
$600.00 K(-87.5%)
$9.40 M(-6.0%)
Dec 1996
$10.00 M(-93.7%)
$4.80 M(+220.0%)
$10.00 M(+53.8%)
Sept 1996
-
$1.50 M(-40.0%)
$6.50 M(-95.9%)
June 1996
-
$2.50 M(+108.3%)
$159.20 M(-0.5%)
Mar 1996
-
$1.20 M(-7.7%)
$160.00 M(+0.2%)
Dec 1995
$159.70 M(+6554.2%)
$1.30 M(-99.2%)
$159.70 M(+0.2%)
Sept 1995
-
$154.20 M(+4572.7%)
$159.40 M(+2798.2%)
June 1995
-
$3.30 M(+266.7%)
$5.50 M(+96.4%)
Mar 1995
-
$900.00 K(-10.0%)
$2.80 M(+16.7%)
Dec 1994
$2.40 M(0.0%)
$1.00 M(+233.3%)
$2.40 M(-7.7%)
Sept 1994
-
$300.00 K(-50.0%)
$2.60 M(0.0%)
June 1994
-
$600.00 K(+20.0%)
$2.60 M(+23.8%)
Mar 1994
-
$500.00 K(-58.3%)
$2.10 M(-12.5%)
Dec 1993
$2.40 M(-91.8%)
$1.20 M(+300.0%)
$2.40 M(+60.0%)
Sept 1993
-
$300.00 K(+200.0%)
$1.50 M(+15.4%)
June 1993
-
$100.00 K(-87.5%)
$1.30 M(-95.7%)
Mar 1993
-
$800.00 K(+166.7%)
$30.10 M(+2.4%)
Dec 1992
$29.40 M(+107.0%)
$300.00 K(+200.0%)
$29.40 M(+1.0%)
Sept 1992
-
$100.00 K(-99.7%)
$29.10 M(+0.3%)
June 1992
-
$28.90 M(>+9900.0%)
$29.00 M(>+9900.0%)
Mar 1992
-
$100.00 K
$100.00 K
Dec 1991
$14.20 M
-
-

FAQ

  • What is IDEXX Laboratories annual cash flow from financing activities?
  • What is the all time high annual CFF for IDEXX Laboratories?
  • What is IDEXX Laboratories annual CFF year-on-year change?
  • What is IDEXX Laboratories quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for IDEXX Laboratories?
  • What is IDEXX Laboratories quarterly CFF year-on-year change?
  • What is IDEXX Laboratories TTM cash flow from financing activities?
  • What is the all time high TTM CFF for IDEXX Laboratories?
  • What is IDEXX Laboratories TTM CFF year-on-year change?

What is IDEXX Laboratories annual cash flow from financing activities?

The current annual CFF of IDXX is -$442.00 M

What is the all time high annual CFF for IDEXX Laboratories?

IDEXX Laboratories all-time high annual cash flow from financing activities is $159.70 M

What is IDEXX Laboratories annual CFF year-on-year change?

Over the past year, IDXX annual cash flow from financing activities has changed by -$71.06 M (-19.16%)

What is IDEXX Laboratories quarterly cash flow from financing activities?

The current quarterly CFF of IDXX is -$290.98 M

What is the all time high quarterly CFF for IDEXX Laboratories?

IDEXX Laboratories all-time high quarterly cash flow from financing activities is $154.20 M

What is IDEXX Laboratories quarterly CFF year-on-year change?

Over the past year, IDXX quarterly cash flow from financing activities has changed by -$247.94 M (-576.10%)

What is IDEXX Laboratories TTM cash flow from financing activities?

The current TTM CFF of IDXX is -$747.13 M

What is the all time high TTM CFF for IDEXX Laboratories?

IDEXX Laboratories all-time high TTM cash flow from financing activities is $160.00 M

What is IDEXX Laboratories TTM CFF year-on-year change?

Over the past year, IDXX TTM cash flow from financing activities has changed by -$290.26 M (-63.53%)